{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:52:45Z","timestamp":1781927565084,"version":"3.54.5"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.2169\/internalmedicine.6357-25","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:05:56Z","timestamp":1762380356000},"page":"1650-1656","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent IgA1-\u03bb-Type PGNMID Achieving Remission with Conventional Immunosuppressive Therapy"],"prefix":"10.2169","volume":"65","author":[{"given":"Kazuki","family":"Chida","sequence":"first","affiliation":[{"name":"Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Oura","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machi","family":"Kiyohara","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaho","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kyo","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ishizuka","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Kamei","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaya","family":"Nakaya","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Fermand JP, Bridoux F, Kyle RA, et al.; the International Kidney and Monoclonal Gammopathy Research Group. How I treat monoclonal gammopathy of renal significance (MGRS). Blood 122: 3583-3590, 2013.","DOI":"10.1182\/blood-2013-05-495929"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bridoux F, Leung N, Hutchison CA, et al.; the International Kidney and Monoclonal Gammopathy Research Group. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int 87: 698-711, 2015.","DOI":"10.1038\/ki.2014.408"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Leung N, Bridoux F, Batuman V, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol 15: 45-59, 2019.","DOI":"10.1038\/s41581-018-0077-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bridoux F, Javaugue V, Nasr SH, Leung N. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective. Nephrol Dial Transplant 36: 208-215, 2021.","DOI":"10.1093\/ndt\/gfz176"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nasr SH, Satoskar A, Markowitz GS, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 20: 2055-2064, 2009.","DOI":"10.1681\/ASN.2009010110"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Soares SM, Lager DJ, Leung N, Haugen EN, Fervenza FC. A proliferative glomerulonephritis secondary to a monoclonal IgA. Am J Kidney Dis 47: 342-349, 2006.","DOI":"10.1053\/j.ajkd.2005.10.023"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Miura N, Uemura Y, Suzuki N, et al. An IgA1-\u03bb-type monoclonal immunoglobulin deposition disease associated with membranous features in a patient with chronic hepatitis C viral infection and rectal cancer. Clin Exp Nephrol 14: 90-93, 2010.","DOI":"10.1007\/s10157-009-0227-x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yahata M, Nakaya I, Takahashi S, Sakuma T, Soma J. Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenstr\u00f6m's macroglobulinemia: case report and review of the literature. Clin Nephrol 77: 254-260, 2012.","DOI":"10.5414\/CN107230"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Yamaguchi Y, Maeda K, Nagatoya K, Yamauchi A. A case report of proliferative glomerulonephritis with monoclonal immunoglobulin M-kappa deposits without associated lymphoproliferative disorder or detectable paraproteinemia. CEN Case Reports 7: 55-61, 2018.","DOI":"10.1007\/s13730-017-0291-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sato K, Makabe S, Iwabuchi Y, et al. Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Nephrology (Carlton) 23: 787-790, 2018.","DOI":"10.1111\/nep.13261"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Li JP, Du YT, Guo C, Rao XR, Li S. IgA nephropathy to proliferative glomerulonephritis with monoclonal IgA\u03ba deposits: a pattern switch. J Nephrol 36: 2375-2380, 2023.","DOI":"10.1007\/s40620-023-01583-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gumber R, Cohen JB, Palmer MB, et al. A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney Int 94: 199-205, 2018.","DOI":"10.1016\/j.kint.2018.02.020"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zhou H, Li M, Zeng C, Chen Z, Zhang T, Cheng Z. Efficacy of immunomodulatory drugs in combination with dexamethasone in proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney Int Rep 7: 2166-2175, 2022.","DOI":"10.1016\/j.ekir.2022.07.009"},{"key":"14","unstructured":"14. Yasumoto Y, Suga T, Miura M, et al. Polyclonal IgA in IgA nephropathy. Ann Acad Med Singap 17: 427-430, 1988."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Liu MY, Xu XJ, Wang SX, et al. Characteristics of complement protein deposition in proliferative glomerulonephritis with monoclonal immunoglobulin deposition. Clin J Am Soc Nephrol 18: 1573-1582, 2023.","DOI":"10.2215\/CJN.0000000000000295"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Vignon M, Cohen C, Faguer S, et al. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits. Kidney Int 91: 720-728, 2017.","DOI":"10.1016\/j.kint.2016.10.026"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Santoriello D, Markowitz GS. Heavy and light chains all at once: a new immunofluorescence technique to evaluate monoclonal immunoglobulin deposits. Kidney Int 100: 22-24, 2021.","DOI":"10.1016\/j.kint.2021.04.022"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nasr SH, Fidler ME, Said SM, Koepplin JW, Altamirano-Alonso JM, Leung N. Immunofluorescence staining for immunoglobulin heavy chain\/light chain on kidney biopsies is a valuable ancillary technique for the diagnosis of monoclonal gammopathy-associated kidney diseases. Kidney Int 100: 155-170, 2021.","DOI":"10.1016\/j.kint.2021.02.038"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/12\/65_6357-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:37:29Z","timestamp":1781926649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/12\/65_6357-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6357-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"6357-25"}}